This case highlights the diagnostic challenges in patients with autoimmune disease receiving anti-tumor necrosis factor (TNF) therapy and underscores the importance of considering multiple sclerosis (MS) in such clinical contexts. The gene discussed is TNF; the disease is myeloid sarcoma.